Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Lovestone

Showing results (131-140 of 333) with videos related to

Pageof 34
Sort By:
Molecular Neurodegeneration|December 11, 2007
Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain sheddingAnnat F Ikin, Mirsada Causevic, Steve Pedrini, et al.
Neuro-Degenerative Diseases|January 5, 2016
Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical AssociationsCamila Orellana, Daniel Ferreira, J-Sebastian Muehlboeck, et al.
Redox Biology|July 14, 2017
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathologyAna I Rojo, Marta Pajares, Patricia Rada, et al.
Acta Neuropathologica Communications|January 11, 2019
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegenerationNicholas J Ashton, Antoine Leuzy, Yau Mun Lim, et al.
Psychiatry Research|April 2, 2013
Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairmentCarlos Aguilar, Eric Westman, J-Sebastian Muehlboeck, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's diseaseAnette Hall, Miguel Muñoz-Ruiz, Jussi Mattila, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2011
Plasma transthyretin as a candidate marker for Alzheimer's diseaseLatha Velayudhan, Richard Killick, Abdul Hye, et al.
Plos One|August 21, 2014
Predicting progression of Alzheimer's disease using ordinal regressionOrla M Doyle, Eric Westman, Andre F Marquand, et al.
Neuroimage|July 19, 2011
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North AmericaEric Westman, Andrew Simmons, J-Sebastian Muehlboeck, et al.
Journal of Alzheimer'S Disease : JAD|December 25, 2014
A phase II trial of tideglusib in Alzheimer's diseaseSimon Lovestone, Mercè Boada, Bruno Dubois, et al.
Pageof 34

Showing results (131-140 of 333) with videos related to

Sort By:
Pageof 34
Molecular Neurodegeneration|December 11, 2007
Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain sheddingAnnat F Ikin, Mirsada Causevic, Steve Pedrini, et al.
Neuro-Degenerative Diseases|January 5, 2016
Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical AssociationsCamila Orellana, Daniel Ferreira, J-Sebastian Muehlboeck, et al.
Redox Biology|July 14, 2017
NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathologyAna I Rojo, Marta Pajares, Patricia Rada, et al.
Acta Neuropathologica Communications|January 11, 2019
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegenerationNicholas J Ashton, Antoine Leuzy, Yau Mun Lim, et al.
Psychiatry Research|April 2, 2013
Different multivariate techniques for automated classification of MRI data in Alzheimer's disease and mild cognitive impairmentCarlos Aguilar, Eric Westman, J-Sebastian Muehlboeck, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's diseaseAnette Hall, Miguel Muñoz-Ruiz, Jussi Mattila, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2011
Plasma transthyretin as a candidate marker for Alzheimer's diseaseLatha Velayudhan, Richard Killick, Abdul Hye, et al.
Plos One|August 21, 2014
Predicting progression of Alzheimer's disease using ordinal regressionOrla M Doyle, Eric Westman, Andre F Marquand, et al.
Neuroimage|July 19, 2011
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North AmericaEric Westman, Andrew Simmons, J-Sebastian Muehlboeck, et al.
Journal of Alzheimer'S Disease : JAD|December 25, 2014
A phase II trial of tideglusib in Alzheimer's diseaseSimon Lovestone, Mercè Boada, Bruno Dubois, et al.
Pageof 34